[HTML][HTML] Drugging IGF-1R in cancer: New insights and emerging opportunities

P Wang, VCY Mak, LWT Cheung - Genes & diseases, 2023 - Elsevier
The insulin-like growth factor (IGF) axis plays important roles in cancer development and
metastasis. The type 1 IGF receptor (IGF-1R) is a key member in the IGF axis and has long …

Pre-clinical and clinical applications of small interfering RNAs (siRNA) and co-delivery systems for pancreatic cancer therapy

S Mirzaei, MH Gholami, HL Ang, F Hashemi, A Zarrabi… - Cells, 2021 - mdpi.com
Pancreatic cancer (PC) is one of the leading causes of death and is the fourth most
malignant tumor in men. The epigenetic and genetic alterations appear to be responsible for …

Knocking down barriers: advances in siRNA delivery

A Rajeev, A Siby, MJ Koottungal, J George… - …, 2021 - Wiley Online Library
RNA interference (RNAi) has been emerged as an effective method to silence a particular
gene utilizing a sequence‐specific mechanism for gene regulation. It induces target mRNA …

Decoding insulin-like growth factor signaling pathway from a non-coding RNAs perspective: a step towards precision oncology in breast cancer

YA ZeinElAbdeen, A AbdAlSeed… - Journal of Mammary Gland …, 2022 - Springer
Breast cancer (BC) is a highly complex and heterogenous disease. Several oncogenic
signaling pathways drive BC oncogenic activity, thus hindering scientists to unravel the …

siRNA and targeted delivery systems in breast cancer therapy

S Mirzaei, MDA Paskeh, M Entezari, SH Bidooki… - Clinical and …, 2023 - Springer
Recently, nucleic acid drugs have been considered as promising candidates in treatment of
various diseases, especially cancer. Because of developing resistance to conventional …

Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy model

A Romeo, A Bonaccorso, C Carbone, G Lupo… - International Journal of …, 2022 - Elsevier
Melatonin (MEL) is a pleiotropic neurohormone of increasing interest as a neuroprotective
agent in ocular diseases. Improving the mucoadhesiveness is a proposed strategy to …

Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells

S Shahidi, K Rostamizadeh, M Fathi, K Nedaei… - … Medicine and Therapies, 2022 - Springer
Background Colorectal cancer (CRC) is the second leading cause of cancer death. Although
Regorafenib showed survival benefits in patients with CRC, reports imply the recurrence of …

Biomaterials and extracellular vesicle delivery: current status, applications and challenges

KS Leung, S Shirazi, LF Cooper, S Ravindran - Cells, 2022 - mdpi.com
In this review, we will discuss the current status of extracellular vesicle (EV) delivery via
biopolymeric scaffolds for therapeutic applications and the challenges associated with the …

Genetically Engineered Membrane‐Coated Nanoparticles as Versatile Platforms with Reduced Protein Corona for Targeted siRNA Delivery

P Zhang, L Zhao, H Liu, H Chen, Y Wu… - Advanced …, 2023 - Wiley Online Library
Low uptake efficiency in vivo as well as systemic toxicities of nucleic‐acid nanovehicles
substantially retard the clinical translation of gene therapy. Targeted gene delivery to …

[Retracted] Design and In Vitro Evaluation of Novel Cationic Lipids for siRNA Delivery in Breast Cancer Cell Lines

S Vaidya, MK Jeengar, MA Wadaan… - Evidence‐Based …, 2022 - Wiley Online Library
Breast cancer is the most common cause of cancer mortality in Western nations, with a
terrible prognosis. Many studies show that siRNA plays a role in the development of tumors …